Gilead Sciences Inc  $80.00

Gilead Sciences, Inc. is a renowned biopharmaceutical company based in Foster City, California, that specializes in discovering, developing, and commercializing innovative medicines to address unmet medical needs. The company is dedicated to preventing and treating various diseases, including HIV, viral hepatitis, cancer, and COVID-19. Gilead Sciences has a strong portfolio of products, which include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla, for HIV/AIDS patients. Its product Veklury is used to treat COVID-19 patients. The firm also offers treatment options for liver diseases, such as Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. In addition, the company provides innovative hematology/oncology/cell therapy solutions, including Yescarta, Tecartus, Trodelvy, and Zydelig. Its other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The firm also distributes generic versions of Epclusa and Harvoni in the United States. Gilead Sciences, Inc. has a commitment to restoring immune balance through agonists targeting immune inhibitory receptors. The company's stock and shares are frequently traded, and investors keep a close eye on its stock price, market cap, and stock price today.